Liprotamase

DRUG7 trials

Sponsors

Anthera Pharmaceuticals

Conditions

Cystic FibrosisExocrine Pancreatic InsufficiencyPancreatic Insufficiency

Phase 2

Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency

CompletedNCT00095732

Anthera PharmaceuticalsCystic Fibrosis, Pancreatic Insufficiency

Start: 2004-06-30End: 2005-03-31Updated: 2014-10-17

Phase 3

Open-Label Phase III Long-Term Safety Trial of Liprotamase

CompletedNCT00449904

Anthera PharmaceuticalsCystic Fibrosis, Exocrine Pancreatic Insufficiency

Start: 2007-06-30End: 2009-04-30Updated: 2014-10-24

Liprotamase Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency

CompletedNCT00449878

Anthera PharmaceuticalsCystic Fibrosis, Exocrine Pancreatic Insufficiency

Start: 2007-05-31End: 2008-06-30Updated: 2014-10-24

Phase III ALTU-135 CP Safety Trial

TerminatedNCT00500084

Anthera PharmaceuticalsExocrine Pancreatic Insufficiency

Start: 2007-12-31End: 2009-03-31Updated: 2014-10-24

SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis

CompletedNCT02279498

Anthera PharmaceuticalsCystic Fibrosis, Exocrine Pancreatic Insufficiency

Start: 2015-06-30End: 2017-01-20Updated: 2018-08-14

RESULT: Reliable, Emergent Solution Using Liprotamase Treatment

Anthera PharmaceuticalsCystic Fibrosis, Exocrine Pancreatic Insufficiency

Start: 2017-04-28End: 2018-06-30Target: 140Updated: 2018-03-08

Phase 4

EASY: Extended Access to Sollpura Over Years

CompletedNCT02823964

Anthera PharmaceuticalsCystic Fibrosis, Exocrine Pancreatic Insufficiency

Start: 2016-09-30End: 2018-03-31Updated: 2018-05-17

Related Papers

A comparison of liprotamase, a non-porcine pancreatic enzyme replacement therapy, to porcine extracted pancrelipase in a noninferiority randomized clinical trial in patients with cystic fibrosis

Clinical Investigation2018-01-018 citations